DrugPatentWatch Database Preview
Polidocanol - Generic Drug Details
What are the generic drug sources for polidocanol and what is the scope of polidocanol freedom to operate?
Polidocanol has one hundred and eighty-five patent family members in thirty-nine countries.
Two suppliers are listed for this compound.
Summary for polidocanol
| International Patents: | 185 |
| US Patents: | 14 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 27 |
| Clinical Trials: | 16 |
| Patent Applications: | 1,817 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | polidocanol at DailyMed |
Pharmacology for polidocanol
| Drug Class | Sclerosing Agent |
| Mechanism of Action | Sclerosing Activity |
| Physiological Effect | Vascular Sclerosing Activity |
Synonyms for polidocanol
| 2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol |
| 3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol |
| 3055-99-0 |
| 9043-30-5 |
| AC1LCVC1 |
| AEO-9 |
| Aethoxy-sklerol |
| AKOS028108701 |
| AN-6543 |
| API0005051 |
| C12E9 |
| C13493 |
| CAS-3055-99-0 |
| CHEBI:46859 |
| CHEMBL1231723 |
| CTK1C2495 |
| D05ZPL |
| DB06811 |
| Detergent Screening Solution 23/Fluka kit no 66317 |
| DODECYL NONA ETHYLENE GLYCOL ETHER |
| Dodecyl nonaethylene glycol ether |
| Dodecylnonaglycol |
| Dodecylnonaoxyethylene glycol monoether |
| DSSTox_CID_19721 |
| DSSTox_GSID_39721 |
| DSSTox_RID_79436 |
| DTXSID5039721 |
| EINECS 221-284-4 |
| genapol X 080 |
| genapol X-080 |
| Genapol X080 |
| GK9185 |
| J-018016 |
| KS-00000Y0K |
| laureth-9 |
| LP016773 |
| Macrogol 9 lauryl ether |
| MFCD00043375 |
| MFCD00163738 |
| MolPort-003-935-762 |
| NCGC00166290-01 |
| NCGC00166290-02 |
| NCGC00166290-03 |
| Nonaethylene glycol monododecyl ether |
| Nonaethylene glycol monododecyl ether, nonionic surfactant |
| nonaethylene glycol monolauryl ether |
| Nonaethyleneglycol monododecyl ether 1 mM solution |
| Nonaethyleneglycol monododecyl ether solution |
| NONAETHYLENEGLYCOLMONODODECYLETHER |
| Oligoethylene glycol monoalkyl ether |
| ONJQDTZCDSESIW-UHFFFAOYSA-N |
| PEG-9 lauryl ether |
| POELE |
| Poly(oxy-1,2-ethanediyl),a-isotridecyl-w-hydroxy- |
| Polydocanol |
| Polyethylene glycol 450 lauryl ether |
| Polyethylene glycol monoalkyl ether |
| Polyethylene glycol monoisotridecyl ether |
| Polyoxyethylen-9-laurylether |
| Polyoxyethylene (9) lauryl ether |
| Polyoxyethylene 9 lauryl ether |
| Polyoxyl 9 lauryl ether |
| SCHEMBL25580 |
| SR-01000944476 |
| SR-01000944476-1 |
| Tox21_112394 |
| Tox21_112394_1 |
| ZINC8214662 |
US Patents and Regulatory Information for polidocanol
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Chemisch Fbrk Krsslr | ASCLERA | polidocanol | SOLUTION;INTRAVENOUS | 021201-001 | Mar 30, 2010 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for polidocanol
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | ➤ Sign Up | ➤ Sign Up |
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Non-Orange Book US Patents for polidocanol
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,763,269 | Therapeutic foam | ➤ Sign Up |
| 8,091,801 | Generation of therapeutic microfoam | ➤ Sign Up |
| 8,048,439 | Therapeutic foam | ➤ Sign Up |
| 9,545,378 | Aerosol valve | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for polidocanol
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Get our Free Drug Patent Bulletin
Join the 27,053 others who get our Drug Patent Expiration Alerts:
- Articles on vital topics
- Fresh industry trends
- Expiring drug patents
- More …
